Patents by Inventor Christelle Carl

Christelle Carl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diazabicyclooctane compounds
    Patent number: 10208041
    Abstract: The present invention relates to compounds according to Formula (II): or a stereoisomer, tautomer or pharmaceutically acceptable salt or ester thereof, wherein A, R1 and R2 are defined herein. Also described are pharmaceutically acceptable compositions of Formula (II) compounds as well as methods for utilizing the compounds of Formula (II) and the pharmaceutically acceptable compositions of Formula (II) compounds as antibacterial agents and ?-lactamase inhibitors, useful in the treatment of infectious diseases.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: February 19, 2019
    Assignee: Hoffman-La Roche Inc.
    Inventors: Paul Spurr, Christelle Carl, Martin Binder, Kewei Yang, Valérie Verhoeven
  • Diazabicyclooctane Compounds
    Publication number: 20180099965
    Abstract: The present invention relates to compounds according to Formula (II): or a stereoisomer, tautomer or pharmaceutically acceptable salt or ester thereof, wherein A, R1 and R2 are defined herein. Also described are pharmaceutically acceptable compositions of Formula (II) compounds as well as methods for utilizing the compounds of Formula (II) and the pharmaceutically acceptable compositions of Formula (II) compounds as antibacterial agents and ?-lactamase inhibitors, useful in the treatment of infectious diseases.
    Type: Application
    Filed: October 5, 2017
    Publication date: April 12, 2018
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Paul SPURR, Christelle CARL, Martin BINDER, Kewei YANG, Valérie VERHOEVEN
  • REVERSED PHASE HPLC PURIFICATION OF A GLP-1 ANALOGUE
    Publication number: 20110313131
    Abstract: The invention comprises a process for the purification of a GLP-1 peptide analogue applying reversed phase high performance liquid chromatography (RP-HPLC).
    Type: Application
    Filed: June 13, 2011
    Publication date: December 22, 2011
    Inventors: Christelle Carl, Michael Rothe, Christian Saladin, Daniel Strub, Francis Vix